UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of combining UCN-01 with carboplatin in treating
patients who have advanced solid tumors. UCN-01 may stop the growth of tumor cells by
blocking the enzymes necessary for tumor cell growth. Drugs used in chemotherapy use
different ways to stop tumor cells from dividing so they stop growing or die. Combining
UCN-01 with carboplatin may kill more tumor cells.